OsoBio delivers the sterile contract manufacturing and drug development services you require—regardless of the scale or complexity of your sterile injectable.

OsoBio was launched in May 2008, when a group of private investors acquired the Albuquerque, New Mexico, sterile injectables manufacturing business from Catalent Pharma Solutions. The company was renamed OSO BioPharmaceuticals Manufacturing, LLC.